Assignee
EVOKE PHARMA INC
US·7 granted patents·9 pending applications·17 citations·filing 2012–2025
Top patents by PatentIndex Score
16 records- 0195US11813231B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Nov 14, 2023·5 cites·20 claims
- 0295US11628150B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2020·Granted Apr 18, 2023·5 cites·30 claims
- 0387US11020361B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2018·Granted Jun 1, 2021·5 cites·17 claims
- 0480US11517545B2Treatment of moderate and severe gastroparesisEVOKE PHARMA INC·Filed 2017·Granted Dec 6, 2022·2 cites·12 claims
- 0580US2025228803A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2024·Application pending·0 cites
- 0677US12194009B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Jan 14, 2025·0 cites·14 claims
- 0777US12194008B2Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2021·Granted Jan 14, 2025·0 cites·17 claims
- 0872US12377064B2Treatment of moderate and severe gastroparesisEVOKE PHARMA INC·Filed 2022·Granted Aug 5, 2025·0 cites·17 claims
- 0971US2025332125A1Treatment of moderate and severe gastroparesisEVOKE PHARMA INC·Filed 2025·Application pending·0 cites
- 1063US2017071885A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2016·Application pending·0 cites
- 1157US2022151960A1Treatment of symptoms associated with female gastroparesisEVOKE PHARMA INC·Filed 2021·Application pending·0 cites
- 1256US2025312297A1Reduction of healthcare resource utilization by patients treated with intranasally-administered metoclopramideEVOKE PHARMA INC·Filed 2025·Application pending·0 cites
- 1352US2025302777A1Methods for treating gastroparesisEVOKE PHARMA INC·Filed 2025·Application pending·0 cites
- 1449US2013213393A1Nasal formulations of metoclopramideEVOKE PHARMA INC·Filed 2012·Application pending·0 cites
- 1545US2020405666A9Treatment of symptoms associated with female gastroparesisEVOKE PHARMA INC·Filed 2018·Application pending·0 cites
- 1636US2020276139A1Methods of intranasal metoclopramide dosingEVOKE PHARMA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EVOKE PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →